Aneurysmal subarachnoid hemorrhage
Drug research and approvals for aneurysmal subarachnoid hemorrhage: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 44 studies of aneurysmal subarachnoid hemorrhage are recruiting on ClinicalTrials.gov, and Health Canada has authorized 5 drug trials for it since 2013.
- Recruiting worldwide: 44
- Trials authorized in Canada: 5
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 44 recruiting on ClinicalTrials.gov ↗- Occurrence of Abdominal Aortic Aneurysms in Patients With Aneurysmal Subarachnoid HemorrhageNCT07312565 · Not reported · Leiden University Medical Center · starts Jun 1, 2026
- Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid HemorrhageNCT07250958 · Not reported · University of Louisville · starts Mar 12, 2026
- Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular EventsNCT06863480 · Phase 1 · University of Florida · starts Mar 2, 2026
- The Effect of Transcutaneous Vagal Nerve Stimulation (tVNS) on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid…NCT07131696 · Not applicable · Marshall Holland · starts Feb 6, 2026
- Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid HemorrhageNCT07294118 · Phase 2 · The University of Texas Medical Branch, Galveston · starts Jan 2, 2026
- Determining the Clinical Impact and Prevalence of Hemorrhagic Subtypes in Perimesencephalic Subarachnoid HemorrhageNCT07923084 · Not reported · Insel Gruppe AG, University Hospital Bern · starts Jan 1, 2026
- Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid HemorrhageNCT07249853 · Phase 3 · Beijing Tiantan Hospital · starts Dec 6, 2025
- Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid…NCT07588997 · Not applicable · National Taiwan University Hospital · starts Nov 23, 2025
- Efficacy of Scalp Block in Managing Post Subarachnoid Hemorrhage Headache in Critically Ill Patients. A Single Centre…NCT07307508 · Not applicable · Hamad Medical Corporation · starts Oct 22, 2025
- DIND in Patients With aSAH : Real World StudyNCT07160088 · Not reported · Xuanwu Hospital, Beijing · starts Sep 3, 2025
Trials Authorized in Canada
Newest first; search them all in Canada trials| Jun 25, 2024 | Safety and tolerability of gtx-104 (nimodipine injection for iv infusion) compared with oral nimodipine in patients hospitalized for aneurysmal subarachnoid…NIMODIPINE (GTX-104) | GRACE THERAPEUTICS INC | Pending |
| Aug 21, 2018 | A prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group, phase 3 study to assess the efficacy and safety of clazosentan in…CLAZOSENTAN | IDORSIA PHARMACEUTICALS LTD | Ongoing |
| Aug 8, 2016 | Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group, efficacy and safety study comparing eg-1962 to standard of care oral…NIMOVENT (EG-1962) | EDGE THERAPEUTICS INC | Ongoing |
| May 1, 2015 | A pilot study of sub-anesthetic ketamine infusion for neuroprotection after aneurysmal subarachnoid hemorrhage: effects on white matter integrity, inflammatory…KETAMINE | DR ANDREW BAKER | Closed |
| Jul 26, 2013 | Phase 1/2a multicenter, controlled, randomized, open-label, dose escalation, safety, tolerability, and pharmacokinetic study comparing eg-1962 and nimodipine…NIMOVENT (EG-1962) | EDGE THERAPEUTICS INC | Closed |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA